Purpose Long COVID, also known as post-acute sequelae of COVID-19, refers to the
constellation of long-term symptoms experienced by people suffering persistent symptoms …

Aims As of the 28th April 2020, the COVID-19 pandemic has infiltrated over 200 countries
and affected over three million confirmed people. We review different biomarkers to evaluate …

The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …

Background Prognostic factors for the Coronavirus disease 2019 (COVID1–9) are not well
established. This study aimed to summarize the available data on the association between …

Background The complications and sequelae of coronavirus disease 2019 (COVID-19) and
their effect on long-term health are unclear, and the trajectory of associated immune …

Context.—An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

The duration and severity of COVID-19 are related to age, comorbidities, and cytokine
synthesis. This study evaluated the impact of these factors on patients with clinical …

Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

The post-acute sequelae of COVID-19 (PASC), also known as long COVID, is often
associated with debilitating symptoms and adverse multisystem consequences. We obtain …